Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FQZDQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,254
Award facts
- Contract value 100% obligated
- $13,253.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,253.95 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle extending through December 2026.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, fulfills critical medical supply needs for military and veteran healthcare systems through its extensive federal contract portfolio. This particular delivery order for Dupixent, a biologic medication used to treat conditions including atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, exemplifies the company's role in supplying specialty pharmaceuticals to the Defense Health Agency and other federal healthcare programs. The DLA's relationship with AmerisourceBergen through the Pharmaceutical Prime Vendor Global Program underscores the vendor's significance in maintaining pharmaceutical supply chain resilience across the Department of Defense and related federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQZDQ?
SPE2DB25FQZDQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FQZDQ worth?
The government has obligated $13,254 on SPE2DB25FQZDQ.
Is contract SPE2DB25FQZDQ an order under another contract?
Yes. SPE2DB25FQZDQ is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQZDQ competed?
The extent of competition for SPE2DB25FQZDQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award